Literature DB >> 29183091

Systematic Review of the Epidemiology and Natural History of the Metabolic Vascular Syndrome and its Coincidence with Type 2 Diabetes Mellitus and Cardiovascular Diseases in Different European Countries.

Caroline Kwasny1, Ulf Manuwald1, Joachim Kugler1, Ulrike Rothe1.   

Abstract

The objectives of this systematic review were to estimate the incidence, prevalence and natural history of the metabolic (vascular) syndrome (MVS) among adults in different European countries. Furthermore, we assessed its co-incidence with type 2 diabetes (T2DM) and cardiovascular diseases (CVD). PubMed, MedLine, and EMBASE (via Ovid) were searched for relevant studies. After reading 116 full-text articles to find eligible ones, 66 publications met our inclusion criteria. Data for the incidence are based on a study from Portugal, in which the incidence rate for the MVS was 47.2/1000 person-years. Prevalence varied strongly depending on country and definition. The lowest was found in the United Kingdom (3%), the highest in Finland (71.7%). No article that deals with the natural history of the MVS was found. Considering the co-existence of MVS and T2DM, it ranged between 2% (United Kingdom) and 74.4% (Spain). The co-occurrence of MVS and CVD ranged from 2.8% (Italy) up to 52% (Netherlands). Coronary heart disease (CHD) varied between 1.2% and 44.2%. With regard to peripheral artery disease (PAD), values between 3.3% and 59.8% were found. Due to the many different definitions of the MVS, a comparison is very difficult. Overall prevalence ranged between 3% and 71.7% depending on definition, age, and country. An association between MVS and T2DM as well as several CVD can be assumed. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 29183091     DOI: 10.1055/s-0043-122395

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  7 in total

Review 1.  Genetic Risk, Adherence to a Healthy Lifestyle, and Ischemic Heart Disease.

Authors:  Thomas F Whayne; Sibu P Saha
Journal:  Curr Cardiol Rep       Date:  2019-01-10       Impact factor: 2.931

Review 2.  Relevance of mitochondrial dysfunction in heart disease associated with insulin resistance conditions.

Authors:  Natalia de Las Heras; Vicente Lahera
Journal:  Pflugers Arch       Date:  2021-11-22       Impact factor: 3.657

3.  Analysis of Risk Factors of Coronary Heart Disease and Its Correlation with Inflammatory Factors in Patients with Type 2 Diabetes Mellitus.

Authors:  Zhigang Wang; Hui Zhao; Qian Zhou
Journal:  Biomed Res Int       Date:  2022-06-24       Impact factor: 3.246

4.  The Antioxidant Activity of Pistachios Reduces Cardiac Tissue Injury of Acute Ischemia/Reperfusion (I/R) in Diabetic Streptozotocin (STZ)-Induced Hyperglycaemic Rats.

Authors:  Rosanna Di Paola; Roberta Fusco; Enrico Gugliandolo; Ramona D'Amico; Michela Campolo; Saverio Latteri; Arianna Carughi; Giuseppina Mandalari; Salvatore Cuzzocrea
Journal:  Front Pharmacol       Date:  2018-02-06       Impact factor: 5.810

5.  Monotherapy of experimental metabolic syndrome: I. Efficacy and safety.

Authors:  Štefan Bezek; Zuzana Brnoliaková; Ružena Sotníková; Vladimír Knezl; Ema Paulovičová; Jana Navarová; Viktor Bauer
Journal:  Interdiscip Toxicol       Date:  2018-02-14

6.  Association of Opium Addiction with Coronary Artery Ectasia and Coronary Artery Disease.

Authors:  Naemeh Bahrami; Gholamreza Asadikaram; Mohammad Masoumi
Journal:  Addict Health       Date:  2021-04

7.  Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient!

Authors:  Niki Katsiki; Maciej Banach; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2019-11-03       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.